NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-182-2017-0-JP-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION JP DIV 2023-220106 Pending
NIAID E-004-2023-1-PC-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES PCT PCT PCT/US2023/085745 Pending
NIAID E-004-2023-0-PC-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES PCT PCT PCT/US2023/085739 Pending
NICHD E-037-2023-0-PC-01 Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation PCT PCT PCT/US2023/085725 Pending
NHLBI E-091-2021-0-CN-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE CN National Stage 202280044857.6 Pending
NIAID E-030-2023-0-PC-01 STABILIZED PFS48/45 PROTEINS AND USES THEREOF PCT PCT PCT/US2023/085849 Pending
NCI E-234-2014-1-US-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF US DIV 18/393,414 Pending
NHLBI E-091-2021-0-US-02 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE US National Stage 18/572,462 Pending
NCI E-106-2021-0-EP-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME EP National Stage 22741091.7 Pending
NIDDK E-112-2021-0-EP-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases EP National Stage 22732782.2 Pending
NCI E-106-2021-0-AU-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME AU National Stage 2022288631 Pending
NEI E-155-2020-0-EP-04 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS EP National Stage 22736412.2 Pending
NCI E-229-2014-0-AU-01 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU DIV 2023285735 Pending
NIAID E-024-2023-0-PC-01 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION PCT PCT PCT/US2023/084255 Pending
NIAID E-216-2021-0-EP-01 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS EP National Stage 22825830.7 Pending
NCI E-171-2020-0-HK-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection HK EP 62023084208.5 Pending
NEI E-153-2020-0-EP-06 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells EP National Stage 22732802.8 Pending
NIAID E-216-2021-0-CA-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Drug Delivery Applications CA National Stage 3222840 Pending
NIAID E-216-2021-0-US-02 Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications US National Stage 18/570,579 Pending
NIAID E-202-2018-0-US-04 USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US CON 18/538,065 Pending
NIAID E-216-2021-0-AU-01 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS AU National Stage 2022293891 Pending
NIAID E-215-2016-1-US-01 PREFUSION PIV F IMMUNOGENS AND THEIR USE US DIV 18/537,448 Pending
NEI E-192-2014-1-EP-10 Surgical Tool and Method for Ocular Tissue Transplantation EP DIV 23215832.9 Pending
NCI E-233-2014-0-AU-01 METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION AU DIV 2023282185 Pending
NCATS E-116-2016-0-JP-01 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE JP DIV 2023-208374 Pending
NIA E-249-2016-0-SG-01 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE SG DIV 10202303473R Pending
NHGRI E-044-2013-1-SG-01 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SG DIV 10202303471P Pending
NCI E-106-2021-0-US-02 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME US National Stage 18/568,738 Pending
NCI E-148-2021-0-US-02 COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER US National Stage 18/568,661 Pending
NCI E-118-2021-0-CN-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors CN National Stage 2022800415318 Pending
NHLBI E-127-2021-2-EP-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES EP National Stage 22726911.5 Pending
NCI E-106-2021-0-JP-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME JP National Stage 2023-575827 Pending
NCI E-106-2021-0-CA-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME CA National Stage 3222837 Pending
NIAID E-150-2021-0-PC-01 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) PCT PCT PCT/US2023/082822 Pending
NIAID E-051-2023-0-PC-01 HYDROGEL PURIFICATION OF CELL MATERIALS FOR PCR-ACTIVATED CELL SORTING PCT PCT PCT/US2023/082816 Pending
NIDDK E-033-2023-0-PC-01 Thyclotide Peptide Conjugates With Cell Permeability And Inhibitory Activity PCT PCT PCT/US2023/082871 Pending
NCI E-118-2021-0-US-02 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors US National Stage 18/567,990 Pending
NCI E-082-2023-0-PC-01 LIGANDS SPECIFIC FOR ASCT1 PCT PCT PCT/EP2023/084599 Pending
NCATS E-091-2016-0-IN-01 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE IN DIV 202318083229 Pending
NCI E-101-2021-0-AU-04 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 AU National Stage 2022268998 Pending
NCI E-099-2014-0-JP-02 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2023-205633 Pending
NIDA E-053-2023-0-PCT-01 FLUORINATED MU-OPIOID RECEPTOR AGONISTS PCT PCT PCT/US2023/082355 Pending
NCI E-142-2022-0-PC-01 Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines PCT PCT PCT/US2023/082186 Pending
NCI E-101-2021-0-KR-06 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 KR National Stage 2023-7041691 Pending
NCI E-183-2017-0-US-02 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS US CON 18/524,799 Pending
NIAAA E-087-2021-0-EP-01 A FACILE AND ODOR-FREE APPROACH TO CONVERT UREA/SULFONYL UREA TO CHALCOGENIDE UREA/ SULFONYL UREA EP National Stage 22729881.7 Pending
NIAID E-131-2020-8-US-01 Anti-Coronavirus Antibodies And Methods Of Use US DIV 18/524,940 Pending
NIAID E-028-2024-0-PC-01 Peptides And Peptide Micro Arrays For Detection And Differentiation Of Antibody Responses To Ebola Virus And Other Pathogens PCT PCT PCT/US2023/081625 Pending
NHGRI E-044-2013-1-AU-01 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA AU DIV 2023274161 Pending
NCI E-171-2018-9-US-08 MODIFIED CELLS AND METHODS OF THERAPY US REEXAM 90/019,313 Pending